63 results
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
8:08am
described above in the description of the Amendment to the Executive Employment Agreements and (y) extend the protection to the executive’s retention … bonus, which was granted pursuant to a retention bonus agreement entered into with each such executive on March 2, 2023, such that the retention bonuses
DRS/A
EX-10
CHRS
Coherus Biosciences Inc
24 Sep 14
Draft registration statement (amended)
12:00am
involving an exception from informed consent.
(b) Monitor such studies to identify when an
Sec. 312.57: Record keeping and record retention
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
5:16pm
and the Company’s respective businesses, operations, supply chain, patient enrollment and retention, preclinical and clinical trials, strategy, goals
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
consulting, severance, change in control, termination pay, retention, bonus, commission or other incentive, equity or equity-based, phantom equity … payments, change in control payments, retention bonus or other incentive payments, or other similar payments or obligations under any Benefit Plan
425
rldmpugi q2t21bd
16 Jun 23
Business combination disclosure
5:17pm
425
cfjgq o9v4d3t5wbbnq
16 Jun 23
Business combination disclosure
5:14pm
425
bt79ylzwgzr7r
16 Jun 23
Business combination disclosure
5:14pm
424B3
ta3f7wuyebye
26 Jul 23
Prospectus supplement
4:59pm
S-4
t36177v7zz6w ifpqe
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
S-4/A
5bna l9fj
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
DRS/A
EX-10
v2zba5fumm8z b03af
24 Sep 14
Draft registration statement (amended)
12:00am
8-K
EX-99.1
r063c unyo6dwgwh
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
fdfp2mx
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
DRS/A
EX-10
x74e08ajucqt8828bu
5 Aug 14
Draft registration statement (amended)
12:00am
425
uek81r 09
16 Jun 23
Business combination disclosure
5:12pm